In February 2026, Labcorp announced nationwide availability of the Elecsys pTau-181 blood test, the first FDA-cleared primary-care tool to aid in ruling out Alzheimer’s disease by identifying ...

A new diagnostic test developed by Indianapolis medical giants can help identify or rule out Alzheimer’s in patients with ...

Elecsys® pTau-181 test helps clinicians rule out Alzheimer's disease by identifying patients unlikely to have amyloid pathologyNow available nationwide in ...

Labcorp is now offering Roche Diagnostics' recently FDA-cleared Alzheimer’s disease blood test to help primary care doctors ...

Detailed price information for Roche Holdings Ltd ADR (RHHBY) from The Globe and Mail including charting and trades.

Ladies and gentlemen, welcome to Roche's Full Year Results Webinar 2025. My name is [ Henrik, ] and I'm the technical operator for today's call. Kindly note that the webinar is being recorded.

For decades, confirming Alzheimer’s disease has meant invasive spinal taps, expensive brain scans, and, too often, waiting until memory loss is unmistakable. Now researchers and regulators are ...

While still in an early stage, interest in testing asymptomatic patients is growing as drug developers explore treating ...

Drugmaker Novartis’ Super Bowl ad explained that prostate cancer screening starts with a simple blood test, aiming to dispel fear of an exam for a treatable cancer.

But psychology offers a more nuanced explanation. Some research suggests that between the ages of about 12 and 25, our brains are especially sensitive to social and cultural cues. During this time, we ...

Counterintuitively, research suggests that moderate narcissism may confer certain adaptive advantages. Some research suggests ...

The convergence of the Artemis II and Crew-12 launch schedules adds another layer of importance to Monday’s countdown test at Kennedy Space Center. For the first time since the 1960s, NASA has ...